Liposome

Items 101-113 of 113

Page
per page
Set Descending Direction
Catalog No.
Product Name
Application
Product Information
Citations
  1. Liposome

    L202 is an ionizable cationic lipid with a pKa of 6.04, designed for the formulation of liposomes. This reagent facilitates the incorporation of mRNA and lipid nanoparticles, making it instrumental in the study of gene delivery and RNA therapeutics. Its unique properties enhance the stability and efficacy of lipid-based delivery systems, thus broadening research applications in mRNA-based therapeutics and nanomedicine.
  2. Liposome

    Biotin-PEGn-NHS ester is a biotinylated linker that facilitates the synthesis of PROTAC molecules by targeting liposomal delivery systems. This compound demonstrates the ability to bind with free neutral avidin, enhancing the specificity for malignant glioma cells. Additionally, Biotin-PEGn-NHS ester can be conjugated to amino groups in GelMA to create biotin-modified functionalized hydrogels, such as gelatin methacryloyl (Bio-GelMA), enabling advanced applications in tissue engineering and drug delivery.
  3. Liposome

    C13-112-tri-tail is a cationic lipid-like compound that features a polar amino alcohol head group, three hydrophobic carbon-13 tails, and a PEG2 linker. This unique composition enables the formulation of lipid nanoparticles (LNPs), which are essential for applications in drug delivery and gene therapy. C13-112-tri-tail serves as an effective component in enhancing cellular uptake and improving the stability of therapeutic payloads in various biochemical and biomedical research settings.
  4. Liposome

    6-(3-Hydroxypropylamino)hexyl 2-hexyldecanoate is an ionizable lipid primarily utilized in the formation of liposomes. This compound features an ester bond near the sixth carbon relative to the amine nitrogen, which may enhance liver clearance. Its properties make it valuable in mRNA delivery systems and other applications in nanomedicine and drug formulation.
  5. Liposome

    1,3-Diolein is a phospholipid that modulates cell membrane fluidity and facilitates signal transduction. This compound is instrumental in cell biology research, providing insights into lipid-mediated signaling pathways and membrane protein interactions. Additionally, 1,3-Diolein functions as an effective carrier in delivery systems, enhancing the bioavailability of various compounds for improved experimental outcomes.
  6. Component Of Liposomes

    N-Palmitoyl-D-sphingomyelin is a key structural component of liposomes, particularly in the formation of low-density lipoprotein (LDL) carriers. This sphingomyelin derivative is utilized in various research applications, including studies focused on colorectal cancer. Its properties facilitate the investigation of lipid-based drug delivery systems and membrane dynamics in biological research.
  7. Liposome

    Monoamine Oxidase B inhibitor 4 is a selective inhibitor of human monoamine oxidase-B (hMAO-B), with an IC50 of 8.3 nM. This compound demonstrates anti-neuroinflammatory properties and exhibits low neurotoxicity. Monoamine Oxidase B inhibitor 4 effectively reduces the release of pro-inflammatory cytokines such as NO, TNF-α, and IL-1β in response to LPS and Aβ1-42, while also mitigating Aβ(1-42)-induced cytotoxicity, making it a valuable tool for research in neurodegenerative diseases and neuroinflammation.
  8. Liposome Component

    Sucrosofate potassium, a sucrose derivative, serves as a crucial component for the preparation of liposomes. Its primary application lies in the formulation of nanoliposomes encapsulating Irinotecan, a potent topoisomerase I inhibitor frequently utilized in colon and rectal cancer research. This formulation enhances the delivery and therapeutic efficacy of Irinotecan, making it a valuable tool in cancer research and drug delivery studies.
  9. Liposome

    Bz-IEGR-pNA acetate is a trypsin substrate that is specifically designed for the evaluation of liposome stability and release profiles. This compound can be hydrolyzed by prostatic kallikrein-related peptidases (KLKs), allowing for the study of enzymatic activity related to prostate tissue. Its primary applications include research into protease activity, drug release mechanisms, and assessment of liposomal formulations in therapeutic contexts.
  10. Liposome

    Boc-Leu-Gly-Arg-pNA acetate is a chromogenic synthetic substrate designed to target and characterize liposomal systems. Its key biological activity includes the release of p-nitroaniline (pNA) upon enzymatic cleavage, facilitating the study of enzyme kinetics and liposome behavior. This reagent serves as a valuable tool in research applications focusing on drug delivery and enzyme activity assays.
  11. Liposome

    Chromozym PL is a chromogenic substrate designed specifically for the enzyme plasmin. This reagent facilitates the detection of enzymatic activity through the generation of p-nitroaniline (pNA) upon hydrolysis. Primarily utilized in liposome studies, Chromozym PL allows for real-time monitoring of plasmin activity in Tris-HCl buffer at pH 7.8, enhancing research in proteolytic processes and biomolecular interactions.
  12. Liposome

    Z-D-Arg-Gly-Arg-pNA dihydrochloride is a hydrolytic chromogenic substrate targeting plasmin. This reagent facilitates the study of fibrinolytic processes by producing a measurable colorimetric change upon plasmin cleavage. It is utilized in various research applications, including assays for thrombolytic activity and the investigation of plasminogen activation dynamics within liposome systems.
  13. Liposome

    SAINT-2 is a cationic lipid that facilitates efficient gene transfection by forming complexes with plasmid DNA. It interacts with molecular membranes to create lipid-plasmid complexes, which are internalized by cells. Upon cellular uptake, phosphatidylethanolamine (DOPE) induces the dissociation of the plasmid from the lipid complex, enabling the plasmid's translocation across endosomal and nuclear membranes. This property makes SAINT-2 a valuable reagent for research applications involving small oligonucleotide delivery in genetic studies and therapeutic development.

Items 101-113 of 113

Page
per page
Set Descending Direction